Developmental nicotine exposure causes persistent changes in cortical neuron morphology and in behavior. We used microarray screening to identify master transcriptional or epigenetic regulators mediating these effects of nicotine and discovered increases in Ash2l mRNA, encoding a component of a histone methyltransferase complex. We therefore examined genome-wide changes in trimethylation of histone H3 on Lys4 (H3K4me3), a mark induced by the Ash2l complex associated with increased gene transcription. A large proportion of regulated promoter sites were involved in synapse maintenance. We found that Mef2c interacts with Ash2l and mediates changes in H3K4me3. Knockdown of Ash2l or Mef2c abolished nicotine-mediated alterations of dendritic complexity in vitro and in vivo, and attenuated nicotine-dependent changes in passive avoidance behavior. In contrast, overexpression mimicked nicotine-mediated alterations of neuronal structure and passive avoidance behavior. These studies identify Ash2l as a target induced by nicotinic stimulation that couples developmental nicotine exposure to changes in brain epigenetic marks, neuronal structure and behavior. npg
High affinity nicotinic acetylcholine receptors (nAChRs) are involved in early brain development, nicotine-mediated alterations of neuronal structure, and persistent changes in behavior 1, 2 . Developmental nicotine exposure induces structural and synaptic changes in the developing brain 3 , and these changes persist into later life 4 . Accordingly, developmental exposure to nicotine is associated with many deleterious effects, including deficits in learning and later development of psychiatric disorders [5] [6] [7] ; however, the molecular mechanisms underlying these effects of cholinergic signaling on early brain development are largely unknown.
We used microarray screening to detect long-term changes in gene expression with the goal of identifying pleiotropic master transcriptional regulators responsible for persistent morphological alterations of cortical neurons. Among identified genes that could alter a transcriptional program, Ash2l, encoding a component of a histone methyltransferase complex, was upregulated by nicotine exposure during development. We therefore used next-generation sequencing to determine whether nicotine could alter histone methylation associated with promoter regions of ensembles of genes involved in neuronal structure. Developmental nicotine exposure enriched trimethylated H3K4 (H3K4me3) at promoter regions of multiple genes involved in development and maintenance of excitatory synapses, including the gene encoding the transcription factor Mef2c, which assembles with Ash2l in a histone methyltransferase complex. This study thus identifies Ash2l as a regulator of neuronal morphology during early brain development and reveals a new molecular mechanism underlying the long-term consequences of developmental nicotine exposure.
RESULTS

Developmental nicotine treatment alters neuronal morphology
Exposure to tobacco smoke during human development can alter cortical structure as measured by diffusion tensor imaging (DTI) 8 . Since nicotine can alter dendritic spine numbers and neuronal morphology 1 , we determined whether nicotine in tobacco smoke could underlie changes in cortical fractional anisotropy measured by DTI. Among regimens used to deliver nicotine during development 7 , drinking water administration results in detectable blood levels in the dam and the offspring and has minimal stressful effects 9 . We therefore exposed mice to saccharin or nicotine (200 µg/ml) from the time of conception through weaning, postnatal day (P) 21, and measured fractional anisotropy at 3 months of age. This regimen results in persistent neurochemical and behavioral changes in exposed pups, with no effects on maternal behavior 10 . Developmental nicotine exposure induced significant increases in fractional anisotropy in a number of cortical areas, largely in gray matter (Fig. 1a,b) . To determine whether changes in gray matter such as spine density and dendritic arborization underlie the increased fractional anisotropy, we labeled neurons diolistically with DiI and performed Sholl analysis and spine counting in mice exposed to nicotine throughout pre-and postnatal development as in the DTI study, as well as in an additional group a r t I C l e S that was treated only from birth to weaning (postnatal exposure), a critical period for cortical development dependent on acetylcholine signaling 11 . Nicotine significantly increased spine density in both the pre-and postnatal nicotine treated group and in the postnatalonly nicotine treated group (Fig. 1c) . There was a significant effect of nicotine treatment on dendritic complexity across rostral, medial and caudal regions of cortex ( Fig. 1d-f ) and across all cortical layers, as demonstrated by a significant nicotine treatment by dendritic complexity interaction in each cortical layer compared to the saccharintreated group (Fig. 1g-i) . These results are consistent with previous studies showing that nicotine can induce persistent changes in spine density 3, 4 . Postnatal-only nicotine-treated mice also showed an increase in dendritic complexity across all cortical regions and layers (Supplementary Fig. 1 ).
Nicotine induces a histone methyltransferase protein
To identify persistent changes in transcriptional regulation that might be responsible for the effects of developmental nicotine treatment on cortical neuron morphology, we performed microarray analysis on mRNA prepared from dissected cortical tissue from mice that were administered saccharin or nicotine throughout the pre-and postnatal period until P21 and were then allowed to remain nicotine-free until Voxel-based analysis of fractional anisotropy changes induced by nicotine treatment during development measured by DTI; diagram from the Paxinos atlas 43 identifies affected regions. Two-tailed t-tests of average fractional anisotropy values in nicotine (Nic) and saccharin (Sac) groups indicate a significant difference (n = 5 brains per condition; t(23) = 3.31, P = 0.00306) in cortical regions investigated, including (a) somatosensory cortex and (b) sensory cortex; **P < 0.01. (c) Nicotine significantly increased spine density in treated groups compared to controls as measured by two-tailed t-test (pre-and postnatal: Sac, n = 26 slices from 6 mice, Nic, n = 25 slices from 5 mice, t 49 = 5.151, P = 0.00000460; postnatal-only: Sac, n = 19 slices from 6 mice, Nic, n = 29 slices from 6 mice, t 46 = 4.96, P = 0.0000100; ***P < 0.001). (d-i) The number of intersections was assessed for the apical dendritic tree as measured by one-way ANOVA followed by LSD test. Scale bar, 12 µm. (d) Frontal cortical regions. F(1,113) = 9.02, P = 0.00329. The parietal (e) and occipital (f) regions of cortex showed a significantly higher number of intersections following nicotine exposure compared to the control group. (e) F(1,48) = 31.9; P = 0.00000085. (f) F(1,38) = 32.1, P = 0.00000165. (g-i) Layer-specific effects of developmental nicotine exposure on dendritic complexity. (g) Superficial layers of cortex showed less change in complexity of dendritic arbors than other layers following early nicotine exposure (nicotine vs. saccharin: F(1,33) = 20.8, P = 0.0000661). Layers (L) 3-4 (h; F(1,85) = 25.9, P = 0.00000210) and 5-6 (i; F(1, 30) = 17.5, P = 0.000203) showed significant nicotine-induced increases in dendritic arborization compared to the control group. *P < 0.05. Frontal: Sac, n = 41; Nic, n = 73; parietal: Sac, n = 29; Nic, n = 23; occipital: Sac, n = 23; Nic, n = 25; L1-2: Sac, n = 20; Nic, n = 15; L3-4: Sac, n = 36; Nic, n = 53; L5-6: Sac, n = 14; Nic, n = 18. n-values represent number of slices from 6 mice. Error bars represent s.e.m. npg a r t I C l e S 3 months of age ( Fig. 2a ; GEO accession code GSE80789). Our goal was to identify master transcriptional regulators that might maintain a program of gene expression responsible for persistent changes in neuronal morphology many weeks after developmental exposure to nicotine. We identified 18 probe sets that were significantly different between developmental nicotine-treated and control animals ( Fig. 2b and Supplementary Fig. 2a ). To determine whether these changes in gene expression were an immediate or a later consequence of developmental nicotine exposure, we evaluated mRNA levels in independent cortical tissue samples by quantitative reverse transcription (qRT)-PCR immediately after nicotine exposure ( Fig. 2c ) or in adulthood (3 months postnatal) following cessation of nicotine exposure (Supplementary Fig. 2b) . At P21, 9 probes identified in the microarray study were significantly induced compared to the control group using qRT-PCR, including Ash2l, Chsy3, Ntrk2, Zfp91, Zcchc11, Cep192, Alkbh1, Ctnnal1, and Tmem107 (Fig. 2c) . Five out of 15 probes initially identified by microarray were significantly different as measured by qRT-PCR compared to the control group at 3 months of age. These included Ash2l, Chsy3, Zcchc11, Cep192, and
Tmem107. Among these, Ash2l was the most highly regulated by two regimens of developmental nicotine treatment ( Fig. 2d,e ) and met our criterion as a master regulator of transcription as measured in muscle development 12 . Ash2l belongs to the trithorax (trx) gene family, a positive regulator of gene transcription particularly critical for development and cell differentiation through trimethylation of H3K4me3 (ref. 13) .
Histone methylation provides a potential mechanism for long-term regulation of gene expression that could maintain the effects of early nicotine exposure into adulthood. We therefore evaluated H3K4me3 across the genome in cortical tissue following pre-and postnatal ( Fig. 3a) and postnatal-only ( Fig. 3b ) nicotine exposure, identifying 14,881 gene loci ( Fig. 3a,b ; GEO accession code GSE80789). Short read sequences from the ELAND pipeline were analyzed for quality control, and those that did not meet criteria for fidelity were discarded. Identified peaks were viewed in Genome Browser and their alignment was verified (examples shown in Fig. 3c ). 367 differentially enriched peaks with adjusted P < 0.05 were identified in cortical samples from pre-and postnatal nicotine exposed mice, and 426 differentially Figure 2 Nicotine exposure during development alters expression of a gene involved in histone methylation. (a) Schematic of developmental nicotine exposure regimens. (b) List of the 18 probes that were significantly different (P < 0.05 as measured by one-way ANOVA) between developmentally treated and untreated animals. Primers (see Supplementary Table 5 ) corresponding to 15 identified probes (excluding unannotated and predicted transcribed probe sets) were used to evaluate mRNA changes in cortical tissue from a separate set of animals using qRT-PCR. (c) Nine of 15 probe sets were significantly altered as measured by one-way ANOVA in independent samples immediately after the cessation of developmental nicotine treatment at P21 (*P < 0.05; **P < 0.01 with Sidak's test; # P < 0.05 with LSD test for multiple comparisons; ) Ash2l mRNA levels were significantly elevated as measured by one-way ANOVA following exposure to nicotine (Nic) as compared to exposure to saccharin (Sac) during development immediately following nicotine exposure (d, P21; F(3,16) = 6.90, P = 0.00341) and in adulthood (e, 3 months of age; F(3,16) = 10.7, P = 0.000413) in samples from mice treated throughout the pre-and postnatal period or during the postnatal period only. *P < 0.05; **P < 0.01; ***P < 0.001 with Sidak's test for multiple comparisons. A total of 20 mice (Nic, n = 10; Sac, n = 10) were used for microarray studies. 5 animals were pooled for each experimental group and two replicate experiments were analyzed. 2 or 3 animals were pooled for each sample for qPCR analysis and 5 samples per each condition were analyzed (P21: Nic, n = 13; Sac, n = 15. 3 months: Nic, n = 11; Sac, n = 15). Whiskers represent minimum to maximum value of data distribution. Center line represents median, and bottom and top of the box represent first and third quartile of data. npg a r t I C l e S enriched peaks were identified from postnatal-only exposed mice ( Fig. 3d and Supplementary Tables 1 and 2) .
Developmental nicotine exposure altered histone methylation at genomic sites responsible for the regulation of synapses, postsynaptic plasticity and cell junctions as identified by gene ontology (GO) analysis (using adjusted P < 0.05; Supplementary Tables 3 and 4) . The genomic sites in these GO categories are highly overlapping (Supplementary Fig. 3a ). Most of the genomic sites identified in this screen are implicated in glutamatergic synaptic transmission (Grin1, Grin2c and Grin2d NMDA receptor subunits) and synapse formation (Dlg2, Camk2a and Dlgap2).
Although there was substantial overlap in genomic sites associated with increased histone methylation in both nicotine-treated groups, developmental nicotine exposure resulted in different effects depending on time and duration of exposure. We identified common genomic sites from gene lists (adjusted P < 0.05) of differentially enriched histone methylation following pre-and postnatal or postnatal-only nicotine exposure (for an example regulated locus, see Supplementary Fig. 3b ). A total of 39 genes showed overlapping changes in both the pre-and postnatal and postnatal-only nicotinetreated group (Supplementary Tables 1 and 2) .
To validate these changes, we tested all 36 overlapping genomic sites (excluding 3 Riken genes with unknown function) using chromosome immunoprecipitation (ChIP) followed by quantitative PCR (qPCR) in independent samples. Thirty-four of 36 tested genomic sites showed significant changes in associated H3K4me3 levels in the pre-and postnatal or postnatal-only groups compared to the control group ( Fig. 3e and Supplementary Fig. 3c ). . Images were acquired using igvtools integrated genome browser and confirmed with UCSC genome browser. The peak distribution pattern of each replicate of a representative locus is shown in Supplementary Figure 3b . H3K4me3 peak height (y axis) plotted against peak width (x axis). x axis length is 15 kb. (d) ChIP-seq analysis identified 367 differentially enriched peaks with adjusted P < 0.05 in cortical samples from mice exposed to nicotine during the pre-and postnatal periods and 426 differentially enriched peaks in cortical samples from mice exposed to nicotine only in the postnatal period as tested by a generalized linear model. (e) Verification of identified gene loci that were enriched following both nicotine exposure regimens using ChIP-PCR showed that 36 of 39 genomic sites identified in the ChIP-seq analysis were differentially methylated in independent samples following pre-and postnatal nicotine exposure compared to the control group as tested by a generalized linear model (*P < 0.05 with LSD test for multiple comparisons; npg a r t I C l e S Nicotine increases histone methylation at the Mef2c locus Given that we were searching for master transcriptional regulators, we selected Mef2c for further functional characterization from among the 34 genomic sites that were verified by ChIP-PCR because the Mef2 family has been identified as part of the histone methylation complex along with Ash2l (ref. 12 ) and also participates in dendritic remodeling during neural differentiation 14, 15 . We first determined whether identified Ash2l and Mef2c binding sites in the genome 16 overlap with the sites of differentially enriched H3K4me3 sites found following developmental nicotine exposure. A large proportion of Ash2l (mouse embryonic stem cell dataset) and Mef2c (early neuronal activity-induced cortical neuron datasets) binding sites overlapped with the H3K4me3 sites found here ( Supplementary Fig. 3d ). GO analysis of these 6,426 overlapping genomic sites (those sites differentially enriched as a result of nicotine exposure that overlapped with previously identified sites of Ash2l and Mef2c binding) identified synapse-related genes as a highly ranked category ( Supplementary Fig. 3d ). This suggested that Ash2l and Mef2c may normally interact at genomic sites related to synaptic function during neuronal development and induce histone trimethylation and transcription of these loci, and that this complex is modulated as a result of developmental exposure to nicotine.
Mef2c expression is normally upregulated during neuronal differentiation and maturation 14, 15 . Although it was not identified in our initial microarray screen, it is likely that the genome-wide evaluation missed some upregulated targets because of stringent statistical cut-offs. We therefore used targeted analyses to determine whether the Mef2c mRNA is regulated following nicotine exposure during development. Using qPCR, we found that Mef2c mRNA levels were elevated in the cortex of mice treated with nicotine throughout development ( Supplementary Fig. 4a ). Mef2c genomic sites also showed elevated H3 acetylation ( Supplementary Fig. 4b) , an additional histone modification related to increased transcription. At 3 months of age, H3K4me3 association with the Mef2c locus was elevated across all regions of cortex as measured by ChIP-PCR following developmental nicotine exposure, although changes were somewhat more modest in the caudal region ( Supplementary Fig. 4c ). These data confirm that histone changes at the Mef2c locus are maintained for a long period following nicotine exposure and that changes in histone methylation and gene expression occur broadly across cortical regions.
Ash2l and Mef2c expression levels are regulated by nAChRs
In vivo genome-wide screening can identify loci that may be relevant for long-term consequences of developmental nicotine exposure, but they cannot distinguish between direct effects of nicotine and indirect changes of downstream pathways. To determine whether alterations of Ash2l and Mef2c levels are due to direct effects of nicotine mediated through nAChRs, we evaluated Ash2l and Mef2c protein levels in cultured neural progenitor cells. After 8-9 d in culture, neural progenitor cells had differentiated into neurons. Cells were treated with nicotine (1 µM) for 48 h and protein levels were examined by western blotting. Nicotine exposure significantly increased Mef2c and Ash2l protein levels as compared to saline treatment ( Fig. 4a,b) . The involvement of nAChR activity in the effects of nicotine on Mef2c and Ash2l expression was verified by exposure to the nicotinic antagonists mecamylamine, α-bungarotoxin, dihydro-β-erythroidine (DHβE) and methyllycaconitine (MLA; Fig. 4a,b) . Mecamylamine npg a r t I C l e S and DHβE significantly attenuated nicotine-induced increases in Ash2l and Mef2c protein levels, whereas α-bungarotoxin and MLA had little effect, suggesting that heteromeric (likely α4and β2-subunit-containing) nAChRs are more likely to contribute to these effects than homomeric nAChRs containing the α7 subunit.
Nicotine depolarizes neurons and increases levels of intracellular calcium, leading to induction of intracellular signaling cascades. To study the role of calcium signaling in nicotine-dependent alterations in Ash2l and Mef2c levels, we grew neural progenitor cells for 8-9 d, then treated them with nifedipine (10 µg/ml) for 48 h with or without nicotine. Treatment with nifedipine blocked the effects of nicotine and significantly reduced basal levels of Ash2l and Mef2c (Fig. 4a,b ), suggesting that expression of these proteins is calcium-dependent and could be induced by depolarization.
Direct interaction of Mef2c and Ash2l was next assessed by coimmunoprecipitation using a Mef2c antibody to pull down Ash2l (Fig. 4c) .
Ash2l was recognized in samples immunoprecipitated with the specific Mef2c antibody, but much less Ash2l was observed in the control sample immunoprecipitated with rabbit immunoglobulin G. Thus, Ash2l and Mef2c form a complex in neural progenitor cells, as has been documented in muscle cells 12 . We next determined whether additional methyltransferase-complex subunits (Wdr5, Mll, Rbbp5) that form a complex with Ash2l in muscle were also present in neural progenitor cells. Wdr5 and Rbbp5 were detected in immunoblots of neural progenitor cell homogenates, and levels of Wdr5 were elevated following treatment of cells with nicotine ( Fig. 4d) . Thus, the methyltransferase complex is expressed in neural progenitors and multiple components are regulated by nicotine signaling.
Ash2l and Mef2c mediate nicotine effects on dendrite morphology
If the Ash2l-Mef2c complex is involved in transcriptional regulation of genes involved in synapse and spine formation, these proteins To determine whether Ash2l and Mef2c are involved in dendritic spine formation, we generated shRNAs specific for mouse Ash2l or Mef2c and transfected these into neural progenitor cells. Downregulation of Ash2l or Mef2c protein was confirmed by western blotting (Supplementary Fig. 5 ).
Neural progenitor cells were transfected with Ash2l shRNA, Mef2c shRNA or scrambled control shRNA ( Fig. 5a-f ) and exposed for 4 d to saline or nicotine. Four days of nicotine exposure significantly increased the number of spines on dendritic shafts of cultured neurons (Fig. 5a,b) . Conversely, knockdown of Ash2l or Mef2c (Fig. 5a,b ) significantly reduced the number of dendritic spines on apical dendrites of cultured neural progenitor cells and abolished the increase in spines induced by 4 d of nicotine exposure.
To determine whether the Ash2l-Mef2c complex could also be critical for effects of nicotine on cortical neuron structure in vivo, in utero electroporation was used to introduce the shRNAs targeting Ash2l or Mef2c into a subset of neurons in the cortex of mice at embryonic day (E) 14. Control (scrambled) shRNA was electroporated into the right hemisphere of a subset of the developing embryos and Ash2l or Mef2c shRNA was electroporated into the left hemisphere of remaining littermates (Supplementary Fig. 6 ). Dams were administered nicotine or saccharin in the drinking water starting from the day of surgery and pups were killed on postnatal day 21 for analysis of cortical neuron dendritic structure. Exposure to nicotine increased dendritic complexity in neurons expressing the scrambled construct, whereas knockdown of Ash2l or Mef2c abolished the ability of nicotine exposure to alter dendritic branching ( Fig. 5c-e) . Consistent with the possibility that the Ash2l-Mef2c complex mediates the effects of nicotine on dendritic structure, overexpression of Ash2l or Mef2c mimicked the ability of nicotine to increase dendritic complexity in the absence of drug exposure (Fig. 5f) .
Similarly, electroporation of the Ash2l shRNA abolished the ability of nicotine to increase density of dendritic spines (Fig. 5g) . Unexpectedly, knockdown of Mef2c resulted in significantly increased basal spine density compared to control animals; however, there was no further increase in spine density by nicotine exposure following Mef2c knockdown (Fig. 5g) . These results suggest that Mef2c signaling likely has multiple roles in spine formation and stabilization 14, [17] [18] [19] [20] [21] [22] but that, among those roles, it contributes to the ability of nicotine to increase spine number. In contrast, overexpression of Ash2l or Mef2c increased spine density (Fig. 5h) .
Ash2l and Mef2c mediate nicotine effects on passive avoidance
Knockdown of Ash2l or Mef2c in vivo prevents developmental nicotine-induced remodeling of dendritic morphology and spine density. In previous studies, we showed that nicotine exposure during the first 3 postnatal weeks induces hypersensitive passive avoidance learning in response to a subthreshold foot shock that is normally ignored 23, 24 . Furthermore, this effect is mediated through β2-subunit-containing nAChRs on corticothalamic neurons. We hypothesized that this behavioral consequence of developmental nicotine exposure could and Mef2c induction. We tested passive avoidance behavior in mice following shRNA-mediated knockdown or cDNA overexpression of Ash2l or Mef2c in sensory cortex via in utero electroporation. While we targeted sensory cortex on the basis of the DTI findings and the role of sensory stimuli in passive avoidance behavior, all animals showed broad cortical expression of the shRNA constructs, and some expression was seen bilaterally. Mice were exposed to saccharin or nicotine from the time of surgery until weaning at P21 (Fig. 6a) . As predicted, nicotine-exposed mice demonstrated hypersensitive passive avoidance performance, as shown by increased latency to enter a dark chamber paired with a mild foot shock, compared to saccharinexposed mice (Fig. 6a) . Cortical delivery of Ash2l or Mef2c shRNA by in utero electroporation significantly attenuated the hypersensitive passive avoidance induced by nicotine ( Fig. 6a) . Despite this attenuation, Ash2l knockdown did not completely abolish the effects of nicotine, likely owing to incomplete knockdown or variability in cortical targeting. Finally, Ash2l or Mef2c overexpression via in utero electroporation mimicked the effect of nicotine exposure, resulting in hypersensitive passive avoidance behavior as compared to that in controls ( Fig. 6b) , demonstrating bidirectional modulation of passive avoidance by Ash2l and Mef2c.
DISCUSSION
The current results demonstrate that Ash2l and Mef2c are critical for the ability of nAChR activity to alter cortical neuron architecture and behavior during development. We propose that nicotine-dependent induction of the Ash2l-Mef2c complex during cortical development induces alterations of histone methylation associated with promoter regions of genes involved in structure and function of glutamatergic synapses and that it increases spine number, dendritic branching and hypersensitive passive avoidance behavior, a behavior modulated by nAChRs expressed in cortical neurons. Together these results identify a molecular mechanism underlying the ability of nAChRs to influence synaptic and dendritic structure and provide a potential cellular mechanism underlying a persistent behavioral consequence of developmental nicotine exposure. Among the small number of genes that are persistently regulated in adulthood following early nicotine exposure, we focused on Ash2l because it fit the profile of a protein that could maintain a broad program of gene expression changes into adulthood. Ash2l is the mammalian homolog of ash2, a gene that belongs to the trithorax (trx) gene family and is a positive regulator of homeotic genes through DNA binding 25 and maintenance of chromatin in a transcriptionally active conformation 26 . The Ash2l gene is highly conserved across evolution and functions as a transcription factor 27 . It is a subunit of several Trx complexes that associate with the Set1 family of histone H3K4 methyltransferases 28 . Decreased expression of Ash2l impairs histone H3K4 trimethylation (H3K4me3) and expression of SET family target genes 29 .
In mammals, Ash2l is expressed in fetal human and mouse brain and its expression decreases in adult tissue 30 . A study of alcoholinduced changes in brain gene expression identified changes in trxrelated genes, including ASH2 (ref. 31 ), suggesting that modulation of Ash2l may also be important for effects of alcohol and other drugs on brain development. According to the Human Proteome Atlas database, Ash2l protein in brain is detected only in neuronal and glial cells of the cerebral cortex and cerebellum 32 . We cannot exclude the possibility that Ash2l signaling in glial cells is involved in nicotine effects on cortical morphology or behavior; however, the in utero electroporation studies may indicate that this is unlikely. Electroporation into the cortex at E14 largely targets pyramidal neurons because GABA interneurons have not yet migrated from the ganglionic eminence at E14, whereas astroglia develop later and electroporated DNA is diluted by the time glia start to differentiate 33 . In addition, the genes most significantly regulated by nicotine exposure during development fall into neuronally relevant GO groups, including those involved in glutamatergic synaptic formation and maintenance. Taken together, these observations support a primary role for Ash2l and Mef2c in neuronal signaling following nicotine exposure during development.
This study also identifies a novel mechanism of gene regulation during brain development that could be more generally involved in activitydependent structural changes of cortical neurons. Ash2l-mediated changes in H3K4me3, specifically at promoters of genes involved in synapse maintenance, likely reflect transcriptional alterations at these loci during a critical period of development that become fixed in the genome 34 . H3K4me3 has been identified as an active promoter mark 35 and may regulate formation of the pre-initiation complex and gene transcription by interacting with other transcription factors 36 .
Of the 34 promoter regions associated with H3K4me3 changes following nicotine exposure, the Mef2c locus is of particular interest because interaction between Ash2l and Mef2d selectively induces trimethylation of H3K4, which subsequently induces gene expression changes required for muscle differentiation 12 . While Mef2c mRNA levels increase in parallel with the increase in H3K4me3 associated with its promoter, it is not yet known whether these histone methylation changes alter Mef2c expression directly. In myoblasts undergoing terminal differentiation, p38α-dependent phosphorylation of Mef2d recruits the Ash2l complex to myogenic gene promoters, enhancing histone H3K4 methylation 12 , promoting formation of the transcription initiation complex and recruiting associated transcription factors that maintain the expression of myogenic genes 37 . Thus, the enrichment of H3K4me3 and persistence of elevated Ash2l expression many weeks after developmental nicotine exposure may maintain transcription of loci associated with H3K4me3 enrichment into adulthood.
Although differential H3K4me3 enrichment is positively correlated with transcription of specific subsets of genes, it is weakly correlated with genome wide transcription changes. The involvement of H3K4me3 in specific gene expression changes is therefore still somewhat controversial. The current study showing differential enrichment of histone methylation at genomic sites following developmental nicotine exposure may suggest that this subset of promoter regions is among those activated by the H3K4me3 mark. While the mechanisms that distinguish genomic loci transcribed as a result of this histone methylation event are not yet clear, the ability of nicotinic signaling to stimulate synaptically related loci may help identify components of the complex that confer specific transcriptional activation. We note that although a small subset of loci were significantly enriched by both pre-and postnatal and postnatal-only nicotine exposure compared to saccharin treatment, 99% of loci identified with the H3K4me3 mark were identified in both nicotine treatment groups. The two regimens of nicotine exposure resulted in differential enrichment of H3K4me3 patterns across this set of gene loci, likely because histone methylation changes are highly dynamic across this period of neural precursor differentiation resulting in a cumulative representation of changes at each stage of development. Thus, the subset of gene loci showing differential H3K4me3 enrichment common to the two regimens of nicotine exposure are likely to be those loci most critical for the functional effects of nicotine on adult neuronal morphology and behavior. Surprisingly, most of the genes implicated in developmental response or neuroadaptation to nicotine are implicated in glutamatergic neurotransmission, synaptic structure or spine formation. a r t I C l e S In addition to its role in the Ash2l complex, the Mef2 family is involved in synaptic maturation and dendritic structure 14, [17] [18] [19] [20] [21] [22] . Members of the Mef2 family are expressed throughout the developing central nervous system 38 and can regulate activity-dependent synaptic morphogenesis in hippocampal neurons 39, 40 . Mef2c regulates gene expression 18, 19 and facilitates neuronal plasticity by regulating synaptic number and function in adult rodents 14 . The identification of mutations in genes regulated by the Mef2 family in human neurological diseases, including autism spectrum disorders, suggests that Mef2 activity is critical for normal brain development. Conditional knockout of the Mef2c gene in mouse brain results in changes in neuronal density, disorganized cortical structure and immature electrophysiological properties, along with abnormalities in anxiety-like behaviors and cognitive tasks 21 . The current results support the idea that Mef2c plays multiple roles in neuronal development, some of which are dependent on Ash2l and others that are likely to be independent.
Although loci with synapse-related functions were most clearly identified by gene ontology analysis following developmental nicotine exposure, genomic sites in the channel binding protein and activity modulator groups were also identified, including a number of calcium and potassium channel subunits (see Supplementary Tables 3  and 4 ). In addition, developmental nicotine administration induced changes in histone methylation of acetylcholine receptor loci, including the α3 subunit of the nAChR (Chrna3) and the muscarinic subunit M1 (Chrm1). Thus, developmental nicotine exposure has persistent effects on histone structure of loci associated with glutamatergic synaptic transmission, neuronal excitability and cholinergic signaling, and common molecular and cellular changes can be induced by different durations of nicotine exposure.
The early postnatal weeks appear to be a critical period for nicotineinduced molecular, cellular and behavioral alterations. The first 2-3 weeks of postnatal development in the mouse corresponds to the third trimester of human pregnancy with respect to cortical synaptic development 41, 42 . Previous studies suggest that stimulation of nAChRs and the resulting calcium influx contributes to maturation of glutamatergic synapses 11 and stimulation of β2* nAChRs induces spine formation in hippocampal and cortical neurons in a cell-autonomous manner 1 . In previous studies we have shown that developmental nicotine exposure during the first 3 weeks of postnatal development induces persistent hypersensitive passive avoidance behavior that lasts into adulthood 23, 24 . Increased passive avoidance learning in response to a mild footshock that is normally ignored could represent an inability to screen out irrelevant sensory stimuli, consistent with the increased incidence of attentional disorders in children exposed in utero to maternal smoking 7 . Maternal smoking is also associated with increased smoking in adult offspring, although this is not modeled with the passive avoidance paradigm. The hypersensitive passive avoidance phenotype requires expression of β2* nAChRs on layer 6 corticothalamic neurons, consistent with the finding that manipulation of Ash2l or Mef2c levels in cortex can modulate passive avoidance learning.
The correlation between the ability of the Ash2l-Mef2c complex to regulate nicotine-dependent remodeling of dendritic morphology and changes in passive avoidance behavior suggest that the alterations in neuronal structure may mediate a persistent behavioral consequence of early nicotine exposure. The current study identifies a molecular mechanism that underlies these cellular and behavioral consequences of nicotine administration. Moreover, the fact that DTI has the sensitivity to detect these morphological changes of dendritic spine density provides clinical opportunities to evaluate these changes in behaving human subjects. In addition to mediating the effects of developmental exposure to the nicotine in tobacco, these molecular mechanisms likely contribute to normal brain development, suggesting that dysregulation of cholinergic induction of Ash2l and Mef2c as a result of genetic or environmental factors could increase the risk for neurodevelopmental disorders such as attention deficit hyperactivity disorder [5] [6] [7] .
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Gene Expression Omnibus: GSE80789.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
ONLINE METHODS
Animals. All procedures were approved by the Yale University Institutional Animal Care and Use Committee and conformed to the standards of the NIH Guide for Care and Use of Laboratory Animals. C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME) used in the developmental nicotine exposure studies acclimated for 1 week, had ad libitum food and water and a 12-h light-dark cycle (lights on at 7 AM).
Reagents. Nicotine hydrogen tartrate (Sigma, St. Louis, MO, USA) was dissolved in phosphate-buffered saline (PBS) pH 7.4 and placed at −20 °C until use. Inhibitors were incubated with the cultures for the following durations before nicotine stimulation: mecamylamine (20 min; Sigma), α-bungarotoxin (α-BTX; 20 min; Sigma and Calbiochem) and nifedipine (15 min; Sigma). Most inhibitors were used at a stock concentration of 1,000×. Anti-Ash2l antibody (Abcam, ab176334) and anti-Mef2c antibody (Cell Signaling, 5030) were validated using cells overexpressing Ash2l and Mef2c. Anti-Wdr5 antibody (Abcam, ab56919) and anti-Rbbp5 antibody (Abcam, ab52084) have been validated in published studies (Supplementary methods checklist) . Anti-β-tubulin antibody (Abcam, ab6046) and anti-Gapdh antibody (Sigma, G8795-200UL) were used as loading controls for western blots and have been validated in published studies (Supplementary methods checklist) . developmental nicotine exposure. After vaginal plug identification, gestating mice were singly housed with ad libitum access to food and water containing 200 µg/ml nicotine hydrogen tartrate (calculated as free base) in 2% (w/v) saccharin or pH-matched 2% saccharin with 0.2% (v/v) tartaric acid (Sigma-Aldrich, St. Louis, MO). Solutions were prepared twice a week. At 21 d, offspring were weaned and left undisturbed until brain tissue collection except for routine husbandry. Female mice were used for genome-wide screening, structural analyses and biochemical studies described below and animals were randomly assigned to treatment groups for all studies. diffusion tensor imaging (dTI) and analysis. The DTI data sets were obtained using a custom-made 43 H radio-frequency volume coil (40 mm diameter) on a 9.4-T horizontal bore magnet (Bruker, Billerica, MA, USA) The DTI experiments were performed using the Stejskal-Tanner spin-echo diffusion-weighted sequence with a diffusion gradient of 5 ms and a delay between the two diffusion gradients of 15 ms as previously described 44 . Briefly, 20 contiguous coronal slices of 0.5 mm thickness were acquired with a repetition time of 2 s and an echo time of 25.1 ms. Two 1-ms Shinnar-Le Roux (SLR) pulses were used for excitation and inversion, respectively. Eighteen averages were acquired and the 128 × 64 images were zero-filled to 256 × 256, resulting in an in-plane resolution of 100 µm × 100 µm. Sixteen different images were acquired for each slice, fifteen corresponding to noncollinear diffusion weighting directions (b = 1,000 s/mm 2 ) and one with no diffusion weighting. In addition, a 256 × 256 fast spin-echo anatomical image was acquired for each brain with the same slice geometry and position as the DTI images. The anatomical image was used for registration of each individual brain to a common reference image.
The diffusion tensor was calculated from the intensities of the 16 diffusionweighted images and the tensor eigenvalues (λ 1 , λ 2 and λ 3 ) were obtained by matrix diagonalization. The fractional anisotropy (FA) was calculated using the following equation:
where λ avg = (λ 1 + λ 2 + λ 3 )/3. The fast spin-echo anatomical images were nonrigidly registered to a reference isotropic anatomical image (100 µm) using a nonlinear intensity-based warping parameterized in terms of a tensor b-spline grid with uniform control point spacing of 1.5 mm. These transformations were used to warp the smoothed FA (Gaussian smoothing σ = 0.2 mm) maps to the same isotropic reference anatomical image at 100 µm resolution. The mean and the s.d. FA maps for both nicotine and saccharin groups were then calculated.
To measure the differences between the two groups, two-tailed t-test maps were generated from the mean and s.d. FA maps. The t-test maps were used to define brain regions (Fig. 1a) for which the mean FA difference becomes significant (P < 0.05). An average FA value was calculated first for each individual brain in each of these regions. Then an average FA value and the corresponding s.d. in these regions were calculated for nicotine and saccharin groups separately.
diolistic labeling of cortical neurons in mouse brain slices. To build a simple path, successive points were selected along the midline of a neural process and the software automatically found a path between them. Connected neural processes were confirmed by generating a 3D reconstruction image. The morphological parameters measured for each apical dendrite and complexity of dendritic arborization were measured using Sholl analysis with NeuronStudio software (MicroBrightField) by calculating the number of crossings that intersected defined concentric circles spaced 10 µm apart, starting from the center of cell body as a function of distance from the soma. Data were based on a total of 214 neurons from 6 animals in the pre-and postnatal nicotine-treated group and 181 neurons from 5 animals in the postnatal-only nicotine-treated group. All data were collected by an investigator blinded to condition. microarray analysis. Mouse tissue samples were cut into slices less than 1 mm in thickness, transferred to Trizol reagent (Invitrogen, Carlsbad, CA) and disrupted with a Dounce tissue homogenizer (Wheaton, Millville, NJ). An equal volume of chloroform was added and samples were centrifuged for 5 min (4 °C, 12,000g). The aqueous phase was transferred to a column from an RNeasy tissue kit (Qiagen, Redwood City, CA) and RNA was isolated according to the manufacturer's recommendations. Subsequently, RNA from 4 animals was pooled to obtain 5 pools per experimental group (20 subjects total). Generation of doublestranded cDNA, preparation and labeling of cRNA, hybridization to GeneChip ® Mouse Genome 430 2.0 Arrays (Affymetrix, Santa Clara, CA) and washing were performed according to the standard Affymetrix protocol. Data analysis was performed using different R packages from the Bioconductor project (http://www. bioconductor.org/). Microarray experiments were done on sample sizes based on successful experiments in the literature. All confirmation experiments were performed on multiple pools of brain samples to reduce biological variability and provide adequate statistical power. chromatin immunoprecipitation (chIP). Mouse tissue samples (50 mg) were cut into slices less than 1 mm in thickness and fixed in 3 ml of 1% formaldehyde/PBS npg solution for 10 min at room temperature to cross-link chromatin DNA and proteins. After being washed with PBS, the tissue samples were homogenized in a glass-Teflon homogenizer. Following homogenization, chromatin was isolated using the Magna ChIP G kit (Millipore, Temecula, CA) according to the Millipore protocol. Briefly, cells were lysed in Cell Lysis Buffer in the presence of protease inhibitor cocktail. Nuclei were isolated from the lysed cells by centrifugation and resuspended in Nuclear Lysis Buffer. The chromatin DNA was then fragmented into the 150-500 base-pair range by sonication using a Branson Sonifier (Danbury, Connecticut).
To immunoprecipitate specific genomic regions of chromatin DNA, the isolated chromatin fragments were incubated with antibodies against histone H3 trimethylated at Lys4 (H3K4-me3, Abcam, Cambridge, MA) and magnetic protein G beads (Millipore) at 4 °C for 2.5 h. Following incubation, the beads were washed with low salt, high salt, LiCl salt, and TE buffers, and chromatin fragments were reverse cross-linked by proteinase K digestion at 62 °C for 2 h.
The eluted DNA was purified after reverse cross-linking by column purification. H3k4me3-specific enrichment was validated by PCR amplification of select positive and negative genomic regions and amplification signals were normalized to the input DNA samples, which were extracted from the same pools of chromatin fragments without enrichment by immunoprecipitation. To control for any differences in DNA across conditions, all ChIP-PCR data were normalized to GAPDH.
High-throughput, massively parallel sequencing. Sample preparation and sequencing on the Genome Analyzer (Illumina, San Diego, CA) were carried out according to the Illumina protocols with some modifications. Briefly, the double-stranded cDNA and ChIP-enriched genomic DNA were treated with T4 DNA polymerase and the Klenow fragment for end repair. The 5′ ends of the DNA fragments were then phosphorylated by T4 polynucleotide kinase, and an adenosine base was added to the 3′ end of the fragments by Klenow (3′-5′ exo). A universal adaptor was then added to both ends of the DNA fragments by A-T ligation. Following 18 cycles of PCR with the Phusion DNA polymerase, the DNA library was then purified on a 2% agarose gel, and fragments 170-300 base pairs in size were recovered. Around 15 ng of the DNA library was then used for cluster generation on a grafted GAII Flow Cell and was then sequenced on the Genome Analyzer for 36 cycles using the sequencing-by-synthesis method.
Sequence base-calling, mapping to genome, data normalization and statistical analysis. Sequences were called from image files with the Illumina Genome Analyzer Pipeline (GApipeline) and aligned to the reference genome (UCSC mm9) using Extended Eland in the GApipeline. Uniquely mapped H3K4-me3 reads for each sample were retrieved from export.txt files (output of Extended Eland). Based on their mapping locations, these selected reads were parsed with in-house Perl scripts to generate base coverage in WIG file format. After moving average smoothing, the chromosome locations of enrichment peaks were identified from pooled WIG files using in-house Perl scripts.
The uniquely aligned reads by ELAND pipeline were considered in calling peaks. To eliminate noise and account for unequal total numbers, we used a defined analysis model (model-based analysis of ChIP-seq, MACS 45 ) with default parameters to find peaks of H3K4me3. For comparison analysis, a customized genomic interval file was created for EdgeR 46 analysis. Gene Ontology analysis was performed by using the Functional Annotation Tool of the DAVID Bioinformatics Resources 6.7, National Institute of Allergy and Infectious Diseases (NIAID), NIH (http://david.abcc.ncifcrf.gov/). Statistical methods were not used to predetermine sample sizes, but n-values were based on published studies. All confirmation experiments were performed on multiple pools of brain samples to reduce biological variability and provide adequate statistical power. cell culture. Neural progenitor cell cultures were generated from C57BL/6J mice at embryonic day 15 as described in the Cold Spring Harbor protocol for neural progenitor cell culture 5 . Each embryonic mouse brain was placed in a clean dish containing ice-cold PBS. Brains were separated into two hemispheres, followed by separation of the dorsal telencephalon. Isolated brain regions were carefully transferred to an untreated polystyrene dish containing cold PBS and tissue was disrupted with a Pasteur pipette. Papain enzyme solution prepared as described in a published protocol 47 was added and incubated for 20 min at 37 °C. Neural progenitor cell medium (NEP) was added after adding enzyme inhibitor solution and centrifugation. Cells were counted using a hemocytometer and 4 × 10 6 cells were added to an untreated culture dish containing NEP medium with EGF and bFGF (NEP complete medium). Once spheres formed, neural spheres were transferred to a PDL-and laminin-coated culture dish. The next day, after the neural spheres settled and attached to the culture dish, NEP complete medium was replaced with NEP medium containing 1% horse serum. For histological analysis, shRNA constructs were introduced into cells at DIV 8-9, when progenitor cells had already differentiated into neurons, and cultures then underwent a further 4 d of exposure to nicotine or saline. Histological analyses were performed at DIV 12-13. western blotting. Approximately 40 µg of each sample was separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. Blots were blocked with 5% milk in Tris-buffered saline with 0.05% (v/v) Tween-20 (TBS-T) for 60 min at 25 °C, washed three times in TBS-T for 15 min, and then incubated at 4 °C overnight in primary antibody diluted in TBS-T. Blots were washed three times in TBS-T and incubated for 60 min at 25 °C in secondary antibody in TBS with 0.1% Tween. Blots were washed three times in TBS-T and two times in water before scanning with an Odyssey Infrared Scanner (Li-Cor Biosciences, Lincoln, NE, USA). The scans were performed with the following scan parameters: intensity = 5.0 for each wavelength (700 and 800 nm), resolution = 169, quality = medium, and focus offset = 0 mm. The scanned intensity of the two secondary antibodies' fluorophores was then used by the Odyssey Software v1.2 (Li-Cor Biosciences) to produce individual images for each wavelength and a pseudocolor overlay of the 700-nm (red) and 800-nm (green) scans. The area of each band was selected for quantification and the integrated intensity of the 700 and 800 nm wavelengths was measured using Odyssey Software without investigator manipulation. Since Li-Cor uses the absolute intensities for quantitation, the pseudocolor images are reflections of the absolute value measured by the program. The integrated intensity values were then exported to Excel (Microsoft, Redmond, WA, USA) for further analysis. For Ash2l expression detection, the Chemiluminescence ECL detection kit (GE Health Care, Pittsburgh, PA, USA) was used.
Immunoprecipitation assay. Approximately 4 × 10 6 neural progenitor cells (NPCs) were treated with nicotine or PBS. Following treatment, NPCs were lysed in RIPA buffer (0.7% sodium deoxycholate, 500 mM LiCl, 50 mM HEPES-KOH, pH 7.6, 1% NP-40, 1 mM EDTA). Samples were sonicated and protein was measured using a D/C protein assay kit (Bio-Rad). 500-1,000 µg of protein was used for each immunoprecipitation assay. The anti-H3K4me3 antibody (Millipore) was coupled to Protein A beads (Novex Lifetechnologies) and immunoprecipitation and elution were performed according to the manufacturer's recommendation. design and construction of shRnAs. shRNAs targeting Ash2l and Mef2c were constructed by selecting unique 24-base or 19-base sequences in the consensus coding region of the mRNA encoding the different isoforms of Ash2l and Mef2c (Ash2l, GenBank accession code NM_011791.3; Mef2c, NM_025282.3) as previously described 48 . A random sequence of 24 bases without similarities to any known mRNA was selected for the scrambled shRNA. Synthetic oligonucleotide duplexes were designed as previously described. Annealed oligonucleotides were ligated into a pAAV-EGFP-shRNA vector as described previously and positive clones were verified by sequencing [48] [49] [50] . Sequences of shRNAs were as follows: Ash2l shRNA 5′ to 3′: (1) GTGCCATCACAGTGGGAATACCTA; (2) GCCATCA CAGTGGGAATACCTACT; (3) CCGGAAGCAAGCAAATTTA. Mef2c shRNA 5′ to 3′: (1) GAATAGTATGTCTCCTGGT; (2) GGTAACCTGAACAAGAATA;
(3) GGACAAACTCAGACATTGT.
In utero electroporation. DNA plasmids encoding either scrambled or Ash2ltargeting shRNA were diluted to a final concentration of 3 µg/µl in PBS containing 0.1% fast green dye tracer. DNA solution (1-2 µl) was unilaterally injected into a lateral ventricle of E14 embryos using a glass pipette and positive pneumatic pressure. PBS-soaked Tweezertrodes with 5 mm electrode diameter (45-0489; BTX) were then positioned across the heads of the embryos followed by five 44-V square pulses lasting 50 ms each at 950 ms interval applied using a pulse generator (ECM830; BTX).
Statistical analysis and computational analysis.
All statistical analyses were accomplished using SPSS (IBM, Inc.). Shapiro-Wilks test of normality and the npg
